monoclonal antibody therapeutics (NRC/CDRD/Kalgene)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namemonoclonal antibody therapeutics (NRC/CDRD/Kalgene)
Drug Alias NamemAbs (NRC/CDRD)monoclonal antibodies (National Research Council/Centre for Drug Research and Development)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGlioblastomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Research Council Canada
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKalgene Pharma IncCentre for Drug Research and DevelopmentNational Research Council Canada
Active IndicationsN/A
Inactive IndicationsGlioblastomaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A